Methylcobalamin is contraindicated in patients with methylcobalamin hypersensitivity or hypersensitivity to any of the medication components
However, patients often report limited effectiveness in reducing curvature
Enriched social environments increase oxytocin and BDNF levels while reducing anxiety-like behaviors (Demirtas et al., 2025
This leads to unpredictable results and potential side effects from contaminants
Lifestyle Interventions: Diet, exercise, and behavioral changes remain foundational for diabetes and obesity management
In the authors anecdotal experience, when further uptitration is not tolerated, but treatment effects are noted, maintaining the patient at the lower tolerated dose may be preferable to discontinuation